{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:33:38Z","timestamp":1778103218451,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To discuss combinations of traditional screening and noninvasive prenatal screening (NIPS) and to compare which traditional screening is the most suitable first-line screening approach to NIPS, pregnant women were recruited in this retrospective observational study. Pregnant women underwent one of four traditional screening tests. The 9 contingent models were combined by high risk cut-offs of 1:50, 1:100, 1:270 and intermediate risk cut-offs of 1:1000, 1:1500, 1:2000. We analyzed cost and performance of various screening models with contingent screening of different risk cut-offs. Compared with other screening tests, combined first-trimester screening (CFTS) had the lowest proportion of high risk (\u22651:270) with the highest detection rate (DR) (78.79%) and the lowest proportion of intermediate risk (1:271~1:1000). When intermediate risk was 1:51 ~1:1500, CFTS as first-line screening had the lowest cost with DR of 93.94%. Other screening tests as the first-line screening with intermediate risk of 1:51~1:1000 had the lowest cost, there DR were 90.91%, 84.62%, 91.67%, respectively. Our study demonstrated if only one traditional screening was allowed to screen pregnant women, CFTS was recommended as the first choice. According to local health and economic conditions, adopting appropriate traditional screening with suitable cut-offs as first-line screening will contributed to a cost-effective screening model.<\/jats:p>","DOI":"10.1038\/s41598-020-66320-2","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T10:02:41Z","timestamp":1591869761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Retrospective Analysis Of Different Contingent Screening Models For Fetal Down Syndrome In Southwestern China"],"prefix":"10.1038","volume":"10","author":[{"given":"Wei","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiwen","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fene","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yepei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"66320_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejogrb.2016.08.038","volume":"206","author":"A Kurtovic-Kozaric","year":"2016","unstructured":"Kurtovic-Kozaric, A. et al. Ten-year trends in prevalence of Down syndrome in a developing country: impact of the maternal age and prenatal screening. Eur. J. Obstet. Gynecol. Reprod. Biol. 206, 79\u201383, https:\/\/doi.org\/10.1016\/j.ejogrb.2016.08.038 (2016).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"66320_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.tjog.2017.10.004","volume":"56","author":"A Vicic","year":"2017","unstructured":"Vicic, A. et al. Prenatal diagnosis of Down syndrome: A 13-year retrospective study. Taiwan. J. Obstet. Gynecol. 56, 731\u2013735, https:\/\/doi.org\/10.1016\/j.tjog.2017.10.004 (2017).","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"66320_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/000992289903800801","volume":"38","author":"VM Kriss","year":"1999","unstructured":"Kriss, V. M. Down syndrome: imaging of multiorgan involvement. Clin. Pediatr. 38, 441\u2013449, https:\/\/doi.org\/10.1177\/000992289903800801 (1999).","journal-title":"Clin. Pediatr."},{"key":"66320_CR4","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1097\/AOG.0000000000001406","volume":"127","author":"Committee on Practice Bulletins-Obstetrics, C. o. G. & the Society for Maternal-Fetal, M.","year":"2016","unstructured":"Committee on Practice Bulletins-Obstetrics, C. o. G. & the Society for Maternal-Fetal, M. Practice Bulletin No. 163: Screening for Fetal Aneuploidy. Obstet. Gynecol. 127, e123\u2013137, https:\/\/doi.org\/10.1097\/AOG.0000000000001406 (2016).","journal-title":"Obstet. Gynecol."},{"key":"66320_CR5","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1016\/j.jogc.2017.06.013","volume":"39","author":"D Chitayat","year":"2017","unstructured":"Chitayat, D., Langlois, S. & Wilson, R. D. No. 261-Prenatal Screening for Fetal Aneuploidy in Singleton Pregnancies. J. Obstet. Gynaecol. Can. 39, e380\u2013e394, https:\/\/doi.org\/10.1016\/j.jogc.2017.06.013 (2017).","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"66320_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/pd.4103","volume":"33","author":"KH Nicolaides","year":"2013","unstructured":"Nicolaides, K. H., Syngelaki, A., Gil, M., Atanasova, V. & Markova, D. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat. Diagn. 33, 575\u2013579, https:\/\/doi.org\/10.1002\/pd.4103 (2013).","journal-title":"Prenat. Diagn."},{"key":"66320_CR7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1311037","volume":"370","author":"DW Bianchi","year":"2014","unstructured":"Bianchi, D. W. et al. DNA sequencing versus standard prenatal aneuploidy screening. N. Engl. J. Med. 370, 799\u2013808, https:\/\/doi.org\/10.1056\/NEJMoa1311037 (2014).","journal-title":"N. Engl. J. Med."},{"key":"66320_CR8","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","volume":"372","author":"ME Norton","year":"2015","unstructured":"Norton, M. E. et al. Cell-free DNA analysis for noninvasive examination of trisomy. N. Engl. J. Med. 372, 1589\u20131597, https:\/\/doi.org\/10.1056\/NEJMoa1407349 (2015).","journal-title":"N. Engl. J. Med."},{"key":"66320_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/uog.15783","volume":"47","author":"MM Gil","year":"2016","unstructured":"Gil, M. M., Revello, R., Poon, L. C., Akolekar, R. & Nicolaides, K. H. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test. Ultrasound Obstet. Gynecol. 47, 45\u201352, https:\/\/doi.org\/10.1002\/uog.15783 (2016).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"66320_CR10","doi-asserted-by":"publisher","first-page":"374 e371","DOI":"10.1016\/j.ajog.2012.08.033","volume":"207","author":"KH Nicolaides","year":"2012","unstructured":"Nicolaides, K. H., Syngelaki, A., Ashoor, G., Birdir, C. & Touzet, G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am. J. Obstet. Gynecol. 207, 374 e371\u2013376, https:\/\/doi.org\/10.1016\/j.ajog.2012.08.033 (2012).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"66320_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/uog.14693","volume":"45","author":"MI Evans","year":"2015","unstructured":"Evans, M. I., Sonek, J. D., Hallahan, T. W. & Krantz, D. A. Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies. Ultrasound Obstet. Gynecol. 45, 74\u201383, https:\/\/doi.org\/10.1002\/uog.14693 (2015).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"66320_CR12","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/pd.4704","volume":"35","author":"W Gyselaers","year":"2015","unstructured":"Gyselaers, W., Hulstaert, F. & Neyt, M. Contingent non-invasive prenatal testing: an opportunity to improve non-genetic aspects of fetal aneuploidy screening. Prenat. Diagn. 35, 1347\u20131352, https:\/\/doi.org\/10.1002\/pd.4704 (2015).","journal-title":"Prenat. Diagn."},{"key":"66320_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/pd.4157","volume":"33","author":"H Cuckle","year":"2013","unstructured":"Cuckle, H., Benn, P. & Pergament, E. Maternal cfDNA screening for Down syndrome\u2013a cost sensitivity analysis. Prenat. Diagn. 33, 636\u2013642, https:\/\/doi.org\/10.1002\/pd.4157 (2013).","journal-title":"Prenat. Diagn."},{"key":"66320_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/pd.4311","volume":"34","author":"N Okun","year":"2014","unstructured":"Okun, N., Teitelbaum, M., Huang, T., Dewa, C. S. & Hoch, J. S. The price of performance: a cost and performance analysis of the implementation of cell-free fetal DNA testing for Down syndrome in Ontario, Canada. Prenat. Diagn. 34, 350\u2013356, https:\/\/doi.org\/10.1002\/pd.4311 (2014).","journal-title":"Prenat. Diagn."},{"key":"66320_CR15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/ajo.12612","volume":"57","author":"S Maxwell","year":"2017","unstructured":"Maxwell, S., O\u2019Leary, P., Dickinson, J. E. & Suthers, G. K. Diagnostic performance and costs of contingent screening models for trisomy 21 incorporating non-invasive prenatal testing. Aust. N. Z. J. Obstet. Gynaecol. 57, 432\u2013439, https:\/\/doi.org\/10.1111\/ajo.12612 (2017).","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"66320_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jogc.2017.05.015","volume":"40","author":"L Nshimyumukiza","year":"2018","unstructured":"Nshimyumukiza, L. et al. Cell-Free DNA-Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis. J. Obstet. Gynaecol. Can. 40, 48\u201360, https:\/\/doi.org\/10.1016\/j.jogc.2017.05.015 (2018).","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"66320_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/ajo.12223","volume":"54","author":"AC Ayres","year":"2014","unstructured":"Ayres, A. C., Whitty, J. A. & Ellwood, D. A. A cost-effectiveness analysis comparing different strategies to implement noninvasive prenatal testing into a Down syndrome screening program. Aust. N. Z. J. Obstet. Gynaecol. 54, 412\u2013417, https:\/\/doi.org\/10.1111\/ajo.12223 (2014).","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"66320_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/gim.2017.188","volume":"20","author":"NJ Wald","year":"2018","unstructured":"Wald, N. J. et al. Prenatal reflex DNA screening for trisomies 21, 18, and 13. Genet. Med. 20, 825\u2013830, https:\/\/doi.org\/10.1038\/gim.2017.188 (2018).","journal-title":"Genet. Med."},{"key":"66320_CR19","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1080\/14767058.2016.1268593","volume":"30","author":"E Colosi","year":"2017","unstructured":"Colosi, E., D\u2019Ambrosio, V. & Periti, E. First trimester contingent screening for trisomies 21,18,13: is this model cost efficient and feasible in public health system? J. Matern. Fetal Neonatal Med. 30, 2905\u20132910, https:\/\/doi.org\/10.1080\/14767058.2016.1268593 (2017).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"66320_CR20","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1080\/14767058.2017.1362383","volume":"31","author":"C Charoenratana","year":"2018","unstructured":"Charoenratana, C. et al. Optimal risk cut-offs for Down syndrome contingent maternal serum screening. J. Matern. Fetal Neonatal Med. 31, 3009\u20133013, https:\/\/doi.org\/10.1080\/14767058.2017.1362383 (2018).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"66320_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.tjog.2018.06.014","volume":"57","author":"RY Lan","year":"2018","unstructured":"Lan, R. Y., Chou, C. T., Wang, P. H., Chen, R. C. & Hsiao, C. H. Trisomy 21 screening based on first and second trimester in a Taiwanese population. Taiwan. J. Obstet. Gynecol. 57, 551\u2013554, https:\/\/doi.org\/10.1016\/j.tjog.2018.06.014 (2018).","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"66320_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.17484","volume":"50","author":"MM Gil","year":"2017","unstructured":"Gil, M. M., Accurti, V., Santacruz, B., Plana, M. N. & Nicolaides, K. H. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet. Gynecol. 50, 302\u2013314, https:\/\/doi.org\/10.1002\/uog.17484 (2017).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"66320_CR23","doi-asserted-by":"publisher","first-page":"e0218166","DOI":"10.1371\/journal.pone.0218166","volume":"14","author":"F Prefumo","year":"2019","unstructured":"Prefumo, F. et al. The contingent use of cell-free fetal DNA for prenatal screening of trisomies 21, 18, 13 in pregnant women within a national health service: A budget impact analysis. PLoS One 14, e0218166, https:\/\/doi.org\/10.1371\/journal.pone.0218166 (2019).","journal-title":"PLoS One"},{"key":"66320_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.11622\/smedj.2015009","volume":"56","author":"SW Li","year":"2015","unstructured":"Li, S. W. et al. The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort. Singap. Med. J. 56, 47\u201352, https:\/\/doi.org\/10.11622\/smedj.2015009 (2015).","journal-title":"Singap. Med. J."},{"key":"66320_CR25","doi-asserted-by":"publisher","first-page":"e005922","DOI":"10.1136\/bmjopen-2014-005922","volume":"4","author":"M Neyt","year":"2014","unstructured":"Neyt, M., Hulstaert, F. & Gyselaers, W. Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis. BMJ Open. 4, e005922, https:\/\/doi.org\/10.1136\/bmjopen-2014-005922 (2014).","journal-title":"BMJ Open."},{"key":"66320_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejogrb.2014.08.028","volume":"182","author":"L Beulen","year":"2014","unstructured":"Beulen, L. et al. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 182, 53\u201361, https:\/\/doi.org\/10.1016\/j.ejogrb.2014.08.028 (2014).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"66320_CR27","doi-asserted-by":"publisher","first-page":"e93559","DOI":"10.1371\/journal.pone.0093559","volume":"9","author":"S Morris","year":"2014","unstructured":"Morris, S., Karlsen, S., Chung, N., Hill, M. & Chitty, L. S. Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down\u2019s syndrome using cell free fetal DNA in the UK National Health Service. PLoS One 9, e93559, https:\/\/doi.org\/10.1371\/journal.pone.0093559 (2014).","journal-title":"PLoS One"},{"key":"66320_CR28","doi-asserted-by":"publisher","first-page":"e0189235","DOI":"10.1371\/journal.pone.0189235","volume":"12","author":"P Guanciali Franchi","year":"2017","unstructured":"Guanciali Franchi, P. et al. Sequential combined test, second trimester maternal serum markers, and circulating fetal cells to select women for invasive prenatal diagnosis. PLoS One 12, e0189235, https:\/\/doi.org\/10.1371\/journal.pone.0189235 (2017).","journal-title":"PLoS One"},{"key":"66320_CR29","unstructured":"China, N. H. C. o. t. P. s. R. o. Technical specification for prenatal screening and diagnosis of fetal cell free DNA, 2016)."},{"key":"66320_CR30","unstructured":"China, N. H. C. o. t. P. s. R. o. Technial standards of prenatal screening and diagnosis for fetal common chromosome abnormalities and open neural tube defects, 2010)."},{"key":"66320_CR31","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa043693","volume":"353","author":"FC Malone","year":"2005","unstructured":"Malone, F. C. JA; Ball, RH; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down\u2019s syndrome. N. Engl. J. Med. 353, 2001\u20132011, https:\/\/doi.org\/10.1056\/NEJMoa043693 (2005).","journal-title":"N. Engl. J. Med."},{"key":"66320_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1017\/S0266462319000308","volume":"35","author":"Y Xu","year":"2019","unstructured":"Xu, Y. et al. Cost-Effectiveness Analysis of Non-invasive Prenatal Testing for Down Syndrome in China. Int. J. Technol. Assess. Health Care 35, 237\u2013242, https:\/\/doi.org\/10.1017\/S0266462319000308 (2019).","journal-title":"Int. J. Technol. Assess. Health Care"},{"issue":"Suppl 3","key":"66320_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/1471-0528.14004","volume":"123","author":"B Li","year":"2016","unstructured":"Li, B. et al. Applicability of first-trimester combined screening for fetal trisomy 21 in a resource-limited setting in mainland China. BJOG 123(Suppl 3), 23\u201329, https:\/\/doi.org\/10.1111\/1471-0528.14004 (2016).","journal-title":"BJOG"},{"key":"66320_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/bdra.20409","volume":"82","author":"Y Chen","year":"2008","unstructured":"Chen, Y. et al. Preliminary study into the economic burden of Down syndrome in China. Birth Defects Res. A Clin. Mol. Teratol. 82, 25\u201333, https:\/\/doi.org\/10.1002\/bdra.20409 (2008).","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66320-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66320-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66320-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:15:22Z","timestamp":1670328922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66320-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66320"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66320-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"11 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9457"}}